Induction of permeability in temozolomide-treated glioma model rats was associated with reduction in tumor volume, increased GFAP expression, and reduced Ki-67 expression, suggesting that BBB permeabilization with this experimental technique can improve delivery of temozolomide to the brain. Here, GFAP is linked to central nervous system cancer.